Results 231 to 240 of about 493,232 (287)

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

open access: yesAdvanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang   +4 more
wiley   +1 more source

The stress-activated kinase p38 mediates non-canonical activation of Src and tyrosine phosphorylation of the adapter protein TAB1. [PDF]

open access: yesJ Biol Chem
Onuma I   +15 more
europepmc   +1 more source

Two-step voltage-sensor activation of the human K<sub>V</sub>7.4 channel and effect of a deafness-associated mutation. [PDF]

open access: yesNat Commun
Nappi M   +9 more
europepmc   +1 more source

Acute arsenic trioxide inhibits the cardiac transient outward K<sup>+</sup> current (I<sub>to</sub>) and human K<sub>v</sub>4.3/KChIP2c channels. [PDF]

open access: yesCurr Res Struct Biol
Mancilla Simbro C   +16 more
europepmc   +1 more source

Unmasking an insulinoma: recurrent Hypoglycemia in a young patient following GLP-1 receptor agonist therapy -A case report. [PDF]

open access: yesOxf Med Case Reports
Baldera-Rodriguez N   +5 more
europepmc   +1 more source

Universal statistics of nanocrystal photoluminescence

open access: yes
Urban A   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy